Profound Medical Corp. PROF NASDAQ

Profound Medical Corp. (PROF) reported total assets of $192.94M and total liabilities of $101.95M for fiscal year 2025, resulting in total equity of $90.99M.

The company held $81.8M in cash and short-term investments. Total debt stood at $6.45M, with net debt of $-75.34M. The Debt-to-Equity (D/E) ratio was 0.07 (conservative).

Current ratio is 12.52, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.07, current ratio of 12.52 — balance sheet is strong
• MOAT (50/100) — Total assets $192.94M and equity $90.99M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.07 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 81/100 with 5/7 criteria passed.

LIVN

LivaNova PLC

$65.14

+0.23%

ITGR

Integer Holdings Corporation

$87.94

-0.78%

AORT

Artivion, Inc.

$37.47

-1.26%

HSKA

Heska Corporation

$119.99

+0.00%

IRMD

IRadimed Corporation

$93.05

-0.55%

FNA

Paragon 28, Inc.

$13.09

+0.00%

SIBN

SI-BONE, Inc.

$14.49

+0.42%

SRDX

Surmodics, Inc.

$42.98

+0.35%